Clarivate's February move that signifies their direction in the future

CENTRAL, Hong Kong - April 19, 2022 - PRLog -- The Board of Directors has approved the open market purchase of up to $1 billion of the Company's ordinary shares through December 31, 2023.

On its 5.25% Series A Mandatory Convertible Preferred Shares, the Board of Directors additionally announced a quarterly dividend of $1.3125 per share, payable in cash on March 1, 2022 to shareholders of record at the close of business on February 15, 2022. Jerre Stead the Executive Chairman and CEO, stated, "Our Board is dedicated to a rigorous capital allocation approach that includes investing to support growth projects and returning cash to shareholders." "We have robust cash flow and feel our current share price offers a compelling investment opportunity," said the company. Following the public presentation of the Company's 2021 financial results and the filing of its annual report on Form 10-K, the repurchase program, which replaces the current repurchase program originally announced in August 2021, is planned to begin.

The Company aims to fund the acquisitions using cash on hand and will seek shareholder permission to enhance its current shareholder authorization, which approved the buying of 50,000,000 ordinary shares, at its next Annual General Meeting of Shareholders.

About this company

Clarivate is a worldwide pioneer in offering solutions that help companies expedite the innovation lifecycle. In the domains of science and intellectual property, our audacious purpose is to help clients solve some of the world's most complex challenges by offering actionable information and insights that shorten the time between fresh ideas and life changing technologies. We use our trusted subscription and technology based solutions, as well as deep subject experience, to help customers find, protect and market their innovations. Please visit clarivate.com for additional details.

For more latest news in US Stock Market you may also visit us at Advisory Access Limited through our website https://advisoryaccessltd.com/ or contact us via email.